These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The choice of an intestinal segment for a urinary conduit. Schlesinger RE, Berman ML, Ballon SC, Lagasse LD, Watring WG, Futoran RJ, Moore JG. Surg Gynecol Obstet; 1979 Jan; 148(1):45-8. PubMed ID: 758696 [No Abstract] [Full Text] [Related]
23. Radical gynecologic surgery for cancer. Hughes SH, Steller MA. Surg Oncol Clin N Am; 2005 Jul; 14(3):607-31, viii. PubMed ID: 15978432 [No Abstract] [Full Text] [Related]
24. [Pelvic exenteration for carcinoma of the uterine cervix (author's transl)]. Mayer M, Bobin JY, Colon J, Borg G. Bull Cancer; 1980 Jul; 67(1):70-7. PubMed ID: 7362891 [Abstract] [Full Text] [Related]
25. Pelvic exenteration for gynecological malignancies: an analysis of 15 cases operated on at a single institution. Mäenpää JU, Kangasniemi K, Luukkaala T. Acta Obstet Gynecol Scand; 2010 Jul; 89(2):279-83. PubMed ID: 19916881 [Abstract] [Full Text] [Related]
27. [Results of 108 exenteration operations in advanced gynecologic cancers]. Friedberg V. Geburtshilfe Frauenheilkd; 1989 May; 49(5):423-7. PubMed ID: 2472302 [Abstract] [Full Text] [Related]
28. The impact of treatment for genital cancer on quality of life and body image--results of a prospective longitudinal 10-year study. Hawighorst-Knapstein S, Fusshoeller C, Franz C, Trautmann K, Schmidt M, Pilch H, Schoenefuss G, Knapstein PG, Koelbl H, Kelleher DK, Vaupel P. Gynecol Oncol; 2004 Aug; 94(2):398-403. PubMed ID: 15297179 [Abstract] [Full Text] [Related]
29. Pelvic exenteration: a perspective from a regional cancer center in India. Pandey D, Zaidi S, Mahajan V, Kannan R. Indian J Cancer; 2004 Aug; 41(3):109-14. PubMed ID: 15472408 [Abstract] [Full Text] [Related]
30. [Total pelvic exenteration for primary and locally recurrent rectal cancer]. Takagi H, Morimoto T, Kato T, Yasue M, Kato K, Yamada E, Hara S, Kido C, Suzuki R, Kuwabara M. Gan No Rinsho; 1984 Nov; 30(14):1779-85. PubMed ID: 6513031 [Abstract] [Full Text] [Related]
32. Rectosigmoid colectomy and reanastomosis to facilitate resection of primary and recurrent gynecologic cancer. Berek JS, Hacker NF, Lagasse LD. Obstet Gynecol; 1984 Nov; 64(5):715-20. PubMed ID: 6387559 [Abstract] [Full Text] [Related]
33. The prognostic significance of ureteral obstruction in patients with recurrent carcinoma of the cervix uteri. Van Dyke AH, Van Nagell JR. Surg Gynecol Obstet; 1975 Sep; 141(3):371-3. PubMed ID: 1162563 [Abstract] [Full Text] [Related]
34. The use of operative laparoscopy in determining eligibility for pelvic exenteration in patients with recurrent cervical cancer. Plante M, Roy M. Gynecol Oncol; 1995 Dec; 59(3):401-4. PubMed ID: 8522264 [Abstract] [Full Text] [Related]
35. Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies. Mourton SM, Chi DS, Sonoda Y, Alektiar KM, Venkatraman ES, Barakat RR, Abu-Rustum NR. Gynecol Oncol; 2006 Mar; 100(3):533-6. PubMed ID: 16226800 [Abstract] [Full Text] [Related]
36. Management of recurrent cervical cancer: the place of ultra-radical surgery. Rogo KO, Stendahl U. East Afr Med J; 1993 Jun; 70(6):380-5. PubMed ID: 8261961 [Abstract] [Full Text] [Related]
37. [Pelvic exenteration for cancer of the uterine cervix (prognostic factors)]. Torres Lobatón A, Bastida Blanco A, Márquez Acosta G, Hernández Aten D, Román Bassaure E, Rojo Herrera G. Ginecol Obstet Mex; 1994 Jul; 62():189-93. PubMed ID: 8063185 [Abstract] [Full Text] [Related]